PACTR201704002117402尚未招募未知
Cepheid GeneXpert®Omni combined with the Xpert® MTB/RIF Ultra for detection of tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis at primary-level diagnostic centres in Tanzania: a pragmatic, cluster-randomized controlled trial (short title: Omni/Ultra Trial)
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 99 Year(s)（—）
- 性别
- All
入选标准
- •Adult 18 years old and above presumptive TB patients
- •Ability to produce sputum
排除标准
- •Presumptive TB patients with symptoms only attributable to extra-pulmonary TB
研究者
相似试验
招募中
不适用
se of Gene Xpert with other methods in diagnosis of Female Genital TuberculosisCTRI/2017/09/009924Central TB Division Ministry of Health and Family Welfare
已完成
不适用
Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the EDReproductive Tract InfectionsNCT01989130George Washington University70
尚未招募
不适用
GeneXpert Performance Evaluation for Linkage to Tuberculosis CareTuberculosisPACTR201610001763265niversity of California San Francisco5,500
进行中（未招募）
不适用
TB-CAPT MTB/XDR StudyResistance BacterialDiagnoses DiseaseTuberculosisNCT04567368Foundation for Innovative New Diagnostics, Switzerland753
已完成
不适用
Xpert Ultra and Xpert HIV-VL in People Living With HIVHIV/AIDSTB - TuberculosisAntiretroviral Therapy, Highly ActiveNCT03187964University of Stellenbosch1,053